SG10201501749WA - Methods for administering long-lasting hypoglycemic agents - Google Patents
Methods for administering long-lasting hypoglycemic agentsInfo
- Publication number
- SG10201501749WA SG10201501749WA SG10201501749WA SG10201501749WA SG10201501749WA SG 10201501749W A SG10201501749W A SG 10201501749WA SG 10201501749W A SG10201501749W A SG 10201501749WA SG 10201501749W A SG10201501749W A SG 10201501749WA SG 10201501749W A SG10201501749W A SG 10201501749WA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- hypoglycemic agents
- administering long
- lasting hypoglycemic
- lasting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82547206P | 2006-09-13 | 2006-09-13 | |
US86839106P | 2006-12-04 | 2006-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201501749WA true SG10201501749WA (en) | 2015-05-28 |
Family
ID=39184534
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201501749WA SG10201501749WA (en) | 2006-09-13 | 2007-09-12 | Methods for administering long-lasting hypoglycemic agents |
SG2011063856A SG174770A1 (en) | 2006-09-13 | 2007-09-12 | Methods for administering long-lasting hypoglycemic agents |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011063856A SG174770A1 (en) | 2006-09-13 | 2007-09-12 | Methods for administering long-lasting hypoglycemic agents |
Country Status (25)
Country | Link |
---|---|
US (3) | US8338369B2 (fr) |
EP (1) | EP2073834B1 (fr) |
JP (2) | JP5524620B2 (fr) |
KR (1) | KR101472601B1 (fr) |
CN (1) | CN103705911A (fr) |
AR (1) | AR062775A1 (fr) |
AU (1) | AU2007296499C1 (fr) |
BR (1) | BRPI0716765A8 (fr) |
CA (1) | CA2662622C (fr) |
CL (1) | CL2007002634A1 (fr) |
CR (1) | CR10684A (fr) |
EA (1) | EA017159B1 (fr) |
ES (1) | ES2442869T3 (fr) |
IL (1) | IL197448A (fr) |
JO (1) | JO2945B1 (fr) |
MA (1) | MA30768B1 (fr) |
MX (1) | MX2009002863A (fr) |
MY (1) | MY149911A (fr) |
NO (1) | NO20091266L (fr) |
NZ (1) | NZ575419A (fr) |
PE (2) | PE20121528A1 (fr) |
SG (2) | SG10201501749WA (fr) |
TW (1) | TWI430806B (fr) |
WO (1) | WO2008033888A2 (fr) |
ZA (1) | ZA200901548B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE029798T2 (en) | 2005-11-04 | 2017-03-28 | Glaxosmithkline Llc | Methods of administering hypoglycemic agents |
PL2373681T3 (pl) * | 2008-12-10 | 2017-07-31 | Glaxosmithkline Llc | Kompozycje farmaceutyczne albiglutydu |
EP2566502A4 (fr) * | 2010-05-04 | 2013-10-09 | Glaxosmithkline Llc | Méthodes de traitement ou de prévention de troubles cardiovasculaires, et de fourniture d'une protection cardiovasculaire |
PT2651398T (pt) | 2010-12-16 | 2018-03-09 | Novo Nordisk As | Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico |
EP2696687B1 (fr) | 2011-04-12 | 2016-10-26 | Novo Nordisk A/S | Dérivés glp-1 double-acylatés |
PT2827845T (pt) | 2012-03-22 | 2019-03-29 | Novo Nordisk As | Composições compreendendo um agente de entrega e sua preparação |
HUE062740T2 (hu) | 2012-03-22 | 2023-12-28 | Novo Nordisk As | GLP-1 peptidek készítményei és elõállításuk |
JP6517690B2 (ja) | 2012-06-20 | 2019-05-22 | ノヴォ ノルディスク アー/エス | ペプチド及び送達剤を含む錠剤製剤 |
KR102272671B1 (ko) * | 2013-05-02 | 2021-07-06 | 노보 노르디스크 에이/에스 | Glp-1 화합물의 경구 투여 |
SI3004155T1 (sl) | 2013-05-28 | 2022-02-28 | Takeda Pharmaceutical Company Limited | Peptidna spojina |
JP6995042B2 (ja) | 2016-05-24 | 2022-02-04 | 武田薬品工業株式会社 | ペプチド化合物 |
BR112020014624A2 (pt) | 2018-02-02 | 2020-12-08 | Novo Nordisk A/S | Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante |
AR125086A1 (es) * | 2021-03-23 | 2023-06-07 | Lilly Co Eli | Composiciones que contienen análogos de incretina y usos de estas |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545618A (en) * | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
US5512549A (en) | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
AU4063697A (en) | 1996-08-08 | 1998-02-25 | Amylin Pharmaceuticals, Inc. | Methods for regulating gastrointestinal motility |
US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
AR022368A1 (es) * | 1998-08-28 | 2002-09-04 | Lilly Co Eli | Procedimiento para administrar peptidos insulinotropicos |
DE60006100T2 (de) * | 1999-05-17 | 2004-07-01 | Conjuchem, Inc., Montreal | Lang wirkende insulinotrope peptide |
US6395767B2 (en) * | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
CZ308214B6 (cs) * | 2000-12-07 | 2020-03-04 | Eli Lilly And Company | GLP-1 fúzní proteiny |
JP2004521093A (ja) * | 2000-12-13 | 2004-07-15 | イーライ・リリー・アンド・カンパニー | グルカゴン様インスリン刺激性ペプチドを用いる長期治療計画 |
WO2002098348A2 (fr) * | 2001-06-01 | 2002-12-12 | Eli Lilly And Company | Formulations de glp-1 a action etalee dans le temps |
EP1432730A4 (fr) * | 2001-08-23 | 2006-10-11 | Lilly Co Eli | Analogues de glp-1 (glucagon-like peptide 1) |
AR036711A1 (es) | 2001-10-05 | 2004-09-29 | Bayer Corp | Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacologico |
IL160917A0 (en) | 2001-10-18 | 2004-08-31 | Bristol Myers Squibb Co | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
EP2261250B1 (fr) * | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | Protéines de fusion d'albumine et GCSF |
WO2003059934A2 (fr) * | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Proteines de fusion d'albumine |
WO2003058203A2 (fr) | 2002-01-08 | 2003-07-17 | Eli Lilly And Company | Analogues de peptide-1 de type glucagon d'extension |
CA2513213C (fr) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Proteines hybrides d'albumine |
CA2545311C (fr) * | 2003-11-12 | 2012-01-03 | Phenomix Corporation | Composes heterocycliques d'acide boronique |
JP4697596B2 (ja) * | 2004-01-13 | 2011-06-08 | 旭硝子株式会社 | 多層積層体 |
HUE027902T2 (en) | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
EP2316446A1 (fr) | 2004-06-11 | 2011-05-04 | Novo Nordisk A/S | Remède contre l'obésité induite par les médicaments au moyen d'agonistes GLP-1 |
HUE029798T2 (en) * | 2005-11-04 | 2017-03-28 | Glaxosmithkline Llc | Methods of administering hypoglycemic agents |
WO2007139589A1 (fr) | 2006-05-26 | 2007-12-06 | Bristol-Myers Squibb Company | Modulateurs des récepteurs de glp-1 à libération prolongée |
-
2007
- 2007-09-11 TW TW096133808A patent/TWI430806B/zh not_active IP Right Cessation
- 2007-09-11 JO JO2007382A patent/JO2945B1/en active
- 2007-09-11 PE PE2012001061A patent/PE20121528A1/es not_active Application Discontinuation
- 2007-09-11 CL CL200702634A patent/CL2007002634A1/es unknown
- 2007-09-11 PE PE2007001215A patent/PE20080840A1/es not_active Application Discontinuation
- 2007-09-12 SG SG10201501749WA patent/SG10201501749WA/en unknown
- 2007-09-12 CN CN201410014248.3A patent/CN103705911A/zh active Pending
- 2007-09-12 SG SG2011063856A patent/SG174770A1/en unknown
- 2007-09-12 ES ES07842306.8T patent/ES2442869T3/es active Active
- 2007-09-12 JP JP2009528440A patent/JP5524620B2/ja active Active
- 2007-09-12 BR BRPI0716765A patent/BRPI0716765A8/pt not_active Application Discontinuation
- 2007-09-12 CA CA2662622A patent/CA2662622C/fr not_active Expired - Fee Related
- 2007-09-12 KR KR1020097007414A patent/KR101472601B1/ko active Protection Beyond IP Right Term
- 2007-09-12 AU AU2007296499A patent/AU2007296499C1/en not_active Ceased
- 2007-09-12 US US12/441,152 patent/US8338369B2/en not_active Expired - Fee Related
- 2007-09-12 MX MX2009002863A patent/MX2009002863A/es active IP Right Grant
- 2007-09-12 NZ NZ575419A patent/NZ575419A/en not_active IP Right Cessation
- 2007-09-12 EA EA200970274A patent/EA017159B1/ru not_active IP Right Cessation
- 2007-09-12 WO PCT/US2007/078226 patent/WO2008033888A2/fr active Application Filing
- 2007-09-12 MY MYPI20090993A patent/MY149911A/en unknown
- 2007-09-12 EP EP07842306.8A patent/EP2073834B1/fr active Active
- 2007-09-12 AR ARP070104049A patent/AR062775A1/es not_active Application Discontinuation
-
2009
- 2009-03-04 ZA ZA2009/01548A patent/ZA200901548B/en unknown
- 2009-03-05 IL IL197448A patent/IL197448A/en active IP Right Grant
- 2009-03-23 CR CR10684A patent/CR10684A/es not_active Application Discontinuation
- 2009-03-26 NO NO20091266A patent/NO20091266L/no not_active Application Discontinuation
- 2009-03-30 MA MA31741A patent/MA30768B1/fr unknown
-
2012
- 2012-06-12 US US13/494,253 patent/US20130005652A1/en not_active Abandoned
-
2013
- 2013-07-19 US US13/946,296 patent/US20140066371A1/en not_active Abandoned
-
2014
- 2014-04-10 JP JP2014081275A patent/JP5753924B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1600047I1 (hu) | Eljárások hipoglikémiás szerek beadására | |
IL197448A0 (en) | Methods for administering long-lasting hypoglycemic agents | |
GB0609492D0 (en) | Therapeutic agents | |
GB0608928D0 (en) | Therapeutic agents | |
GB0601962D0 (en) | Therapeutic agents | |
WO2007082127A8 (fr) | Thérapie de combinaison pour ckrtm durable | |
EP2092892A4 (fr) | Ultrasonographe | |
EP2014237A4 (fr) | Échographe | |
GB0606287D0 (en) | Syringe | |
GB0616214D0 (en) | Therapeutic Agents | |
EP1997436A4 (fr) | Ultrasonographe | |
GB0611152D0 (en) | Therapeutic agents | |
GB0603926D0 (en) | Syringes | |
GB0620818D0 (en) | Therapeutic agents | |
EP2015810A4 (fr) | Seringue améliorée | |
GB0625783D0 (en) | Medicament | |
GB0620059D0 (en) | Therapeutic agents | |
EP2060233A4 (fr) | Échographe | |
GB0609676D0 (en) | Therapeutic agents | |
GB0615064D0 (en) | Medicament | |
EP2047804A4 (fr) | Ultrasonographe | |
GB0615814D0 (en) | Medicament | |
GB0622195D0 (en) | Therapeutic agents | |
ZA200809732B (en) | Single use syringe | |
ZA200708369B (en) | Medicament |